The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2026 | Concept of cure in multiple myeloma: a patients perspective
Jenny Ahlstrom, HealthTree Foundation, South Jordan, UT, discusses the concept of a cure in multiple myeloma from a patient’s perspective, noting that while patients are excited about the possibility of a cure, they are also cautious because of the risk of relapse. She notes that patients generally consider being off treatment as a key aspect of a cure, but emphasizes the need for ongoing monitoring and careful communication from the medical community to avoid misconceptions. This interview took place at the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
